Loading
Total declarations
Company
▲ Purchases (43 ops.)
▼ Sales (14 ops.)
Latest filing published 24 Jul 2026 for Simcere Pharmaceutical Group Ltd..
Filing timeline
BuySaleREN Jinsheng
Insider track record
Disclosed buys
43
Disclosed sells
14
Signal history
No signal scores available.
Closed purchases
Market purchases
43
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- +15.0%Entry HK$9.58 · Close 16 Oct 2026 HK$11.02
- +16.7%Entry HK$9.44 · Close 16 Oct 2026 HK$11.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
REN Jinsheng: trading record in brief
REN Jinsheng is a declared insider of Simcere Pharmaceutical Group Ltd. (chief executive), with filings sourced from HKEX. We count 60 filings; the first trade dates from 27 October 2020 and the latest from 13 July 2026.
In open-market terms, that means 43 purchases worth €3.3M on one side and 14 sales on the other. The amount is not disclosed for 45 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 2 purchases and 6 sales on the market.
Half of the purchases are above €320k and half below.
The newest entry dates from 24 July 2026: an open-market sale, in Simcere Pharmaceutical Group Ltd. The last purchase on record was published on 17 June 2026, which is 129 days ago. Filings reach the HKEX feed a median of 5 days after the trade. Until a filing is published, the market cannot know about the trade. Source: insider filings from HKEX. Past trades are no guide to future returns.
Companies and markets linked to REN Jinsheng
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations60 total
47,000 sharesShareXHKGHKEX:DA20260724E00215
53,000 sharesShareXHKGHKEX:DA20260723E00383
100,000 sharesShareXHKGHKEX:DA20260723E00305
100,000 sharesShareXHKGHKEX:DA20260713E00576
100,000 sharesShareXHKGHKEX:DA20260709E00489
100,000 sharesShareXHKGHKEX:DA20260617E00028
Canonical exit: 13 Sept 2026 (T+90)
100,000 sharesShareXHKGHKEX:DA20260615E00354
Canonical exit: 8 Sept 2026 (T+90)
44,952,853 sharesShareXHKGHKEX:DA20260413E00571
0ShareXHKGHKEX:DA20231026E00459
45,380,245 sharesShareXHKGHKEX:DA20230922E00284
164,000 sharesShareXHKGHKEX:DA20230830E00268
100,000 sharesShareXHKGHKEX:DA20230828E00348
Canonical exit: 21 Nov 2023 (T+90)
200,000 sharesShareXHKGHKEX:DA20230828E00344
Canonical exit: 20 Nov 2023 (T+90)
200,000 sharesShareXHKGHKEX:DA20230825E00409
Canonical exit: 20 Nov 2023 (T+90)
195,000 sharesShareXHKGHKEX:DA20230703E00459
Canonical exit: 26 Sept 2023 (T+90)
268,000 sharesShareXHKGHKEX:DA20230629E00456
Canonical exit: 24 Sept 2023 (T+90)
537,000 sharesShareXHKGHKEX:DA20230628E00434
Canonical exit: 21 Sept 2023 (T+90)
1,681,000 sharesShareXHKGHKEX:DA20230627E00367
Canonical exit: 19 Sept 2023 (T+90)
100,000 sharesShareXHKGHKEX:DA20230627E00364
100,000 sharesShareXHKGHKEX:DA20230621E00345
Canonical exit: 14 Sept 2023 (T+90)
360,000 sharesShareXHKGHKEX:DA20230621E00344
315,000 sharesShareXHKGHKEX:DA20230620E00444
100,000 sharesShareXHKGHKEX:DA20230619E00329
Canonical exit: 12 Sept 2023 (T+90)
386,000 sharesShareXHKGHKEX:DA20230619E00328
300,000 sharesShareXHKGHKEX:DA20230613E00497
Canonical exit: 6 Sept 2023 (T+90)
25 of 60 declarations
